摘要
糖尿病合并骨质疏松症(Diabetic ostecporosis,DOP)是指以高血糖和骨密度减低为特点的内分泌代谢性疾病。随着糖尿病发病率的逐年上升,糖尿病合并骨质疏松症逐渐成为老年糖尿病患者面临的严重并发症,中医界对糖尿病合并骨质疏松症的病机认识和防治逐渐深入,且在临床实践中取得明显疗效。本文综述了老年糖尿病合并骨质疏松症的发病机制、危险因素以及中医证候研究现状。
Diabetic ostecporosis（DOP） refers to the endocrine and metabolic disease characterized by hyperglycemia and reduced bone mineral density. With the annually increasing incidence of diabetes,DOP is gradually becoming the severe complication that senile patients with diabetes may face. In Chinese medicine, the understanding of its pathogenesis, prevention and treatment progressively deepens,and significant therapeutic effect has been gotten in the clinical practice. This article reviewed the current research status of DOP in respect of its pathogenesis,risk factors and Chinese medicine syndrome.
作者
安艳军
曹天一
牟新
AN Yanjun;CAO Tianyi;MOU Xin
出处
《新中医》
CAS
2018年第10期22-25,共4页
New Chinese Medicine
